TY - JOUR T1 - USA Winter 2021 CoVID-19 Resurgence Post-Christmas Update JF - medRxiv DO - 10.1101/2022.02.04.22270491 SP - 2022.02.04.22270491 AU - Genghmun Eng Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/02/06/2022.02.04.22270491.abstract N2 - We have successfully modeled every USA CoVID-19 wave using: where N (t) is the total number of new CoVID-19 cases above a prior baseline, and tR sets the doubling time tdbl = tR (ln 2). The new parameters {αS ; δo} measure mitigation efforts among the uninfected population, with {αS > 0} being associated with Social Distancing and vaccinations ; while {δo > 0 }is associated with mask-wearing, which gives a faster post-peak drop-off. The predicted pandemic wave end is when N (t) no longer increases.Using data from 11/15/21-12/30/21, our prior medrxiv.org preprint* showed this initial Omicron CoVID-19 wave had values that matched the initial stage of the prior USA Winter 2020 resurgence {tR ≈8 05 days ; αS ≈ 0 011 / day}, when practically no one was vaccinated. In addition, this initial Winter 2021 wave showed virtually no mask-wearing {δo ≈ × 0 001 10−3 / day}, making it capable of infecting virtually everyone. These parameter values indicated that the Omicron variant was likely evading the vaccines in people who thought they were protected.As a result, stopping the Omicron CoVID-19 spread must once again rely on enhanced Social Distancing and mask-wearing, just like the initial pandemic wave in March 2020. Analyzing the USA follow-on data from 12/25/21-1/31/22 shows that people did exactly that after the Christmas Holiday season, resulting in the following model parameters and values: for this wave by itself, with all prior waves subtracted out as a baseline. Combining all the USA CoVID-19 waves gives these updated totals: assuming no future CoVID-19 Resurgence (with 4 Figures).*(10.1101_2021.10.15.21265078)Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All CoVID-19 pandemic data used here is from the publicly available bing.com CoVID-19 Tracker site.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript. ER -